Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852. NDC 71384-746-06.
Class I - DangerousWhat Should You Do?
- Check if you have this product: Lot: 25JAN033A, 25JAN033B, Expires: 02/12/2026.
- Do not eat it: Even if it looks and smells fine, do not consume this product.
- Throw it away or return it: You can return the product to the store for a full refund.
- Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
- Report problems: Report any issues to the FDA's Safety Reporting Portal.
⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.
Recall Details
- Company:
- Imprimis NJOF, LLC
- Reason for Recall:
- Presence of particulate matter - Glass like particles.
- Classification:
- Class I - Dangerous
Dangerous or defective products that predictably could cause serious health problems or death.
- Status:
- ongoing
Product Information
Full Description:
Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852. NDC 71384-746-06.
Product Codes/Lot Numbers:
Lot: 25JAN033A, 25JAN033B, Expires: 02/12/2026.
Official Source
Always verify recall information with the official FDA source:
View on FDA.govFDA Recall Number: D-0251-2026
Related Recalls
Class I - Dangerous
Presence of particulate matter - Glass like particles.
Class I - Dangerous
Presence of particulate matter - Glass like particles.
Class I - Dangerous
Subpotent Drug